We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZM:NASDAQZoom Communications, Inc. Analysis

Data as of 2026-09-09 - not real-time

$96.44

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Zoom Communications, Inc. trades at $96.44, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has gained 5.7% over the past 30 days. RSI sits at 46.0, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $92.72 and resistance around $110.89.
The shares look undervalued, trading on 9.0 times earnings below a sector average of 33.3. The average analyst target implies 22.6% above today's level. Revenue is growing at 4.9% on a 65.2% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 48.2%, a beta of 0.92 and a maximum drawdown of 25.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 8 out of 10.

Top Market Events

$ZM is up nearly 22% year-to-date amid a pivot into “AI-first” enterprise productivity software.What Happened? Shares of video communications platform Zoom NASDAQ:ZM jumped 3.6% in the afternoon session after the...Zoom Communications ZM closed the most recent trading day at $107.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 90.51
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 9.0 versus sector average of 33.3
  • Trading above the 200-day average of 90.51

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • P/E of 9.0 versus sector average of 33.3
  • Analyst targets imply +22.6% versus the current price
  • Profit margin of 65.2% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin65.19%
P/E Ratio9.0
ROE32.14%
ROA6.11%
Debt/Equity0.53
P/B Ratio2.8
Op. Cash Flow$2.0B
Free Cash Flow$2.0B
Industry P/E33.3

Technical Analysis

TrendBullish
RSI46.0
Support$92.72
Resistance$110.89
MA 20$102.00
MA 50$96.07
MA 200$90.51
MACDBearish
VolumeIncreasing
Fear & Greed Index93.36

Valuation

Fair Value$130.18
Target Price$118.24
Upside/Downside22.60%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.92
Volatility48.21%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.